Aarti Pharmalabs balance sheet

As of Sep 2026

Total assets: ₹3,826cr+17.1% on Sep 2025
Shareholders' equity: ₹2,255cr+10.2% on Sep 2025
Total debt: ₹836cr+42.0% on Sep 2025
Cash and investments: ₹4.2cr−86.9% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1,466	1,336	1,104	1,015	923
	308	305	307	78.5	62.2
	65.5	65.5	—	0.0	—
	0.0	0.0	1.8	1.8	1.8
	34.6	36.0	30.7	16.9	1.3
	104	87.9	67.8	58.4	39.7
	—	—	—	36.8	—
	204	194	29.2	0.0	35.5
	8.0	7.8	7.3	5.9	0.0
	36.3	35.4	14.0	11.3	9.5
	248	237	50.6	17.2	45.0
	8.6	16.8	22.7	12.3	2.5
	2,169	2,084	1,584	1,236	1,075
	794	640	588	643	602
	0.0	0.0	47.6	70.4	38.2
	685	583	575	519	440
	4.2	8.5	6.7	23.6	24.9
	19.1	1.1	1.9	0.4	0.1
	0.6	0.5	1.0	1.3	7.1
	0.2	154	5.1	6.3	35.8
	709	747	638	621	546
	153	—	96.8	78.0	7.6
	1,657	1,397	1,322	1,346	1,156
	3,826	3,482	2,906	2,582	2,231
Equity
	45.3	45.3	45.3	45.3	45.3
	2,209	2,079	1,945	1,712	1,513
	2,255	2,125	1,990	1,757	1,558
	2,255	2,125	1,990	1,757	1,558
Liabilities
	160	186	104	0.0	0.2
	80.3	91.5	19.4	16.7	0.5
	240	277	123	16.7	0.7
	9.1	7.9	8.1	6.1	1.3
	143	134	128	108	78.8
	392	420	259	131	80.9
	677	500	293	264	214
	363	335	278	378	347
	95.4	81.7	56.4	34.7	16.9
	1,135	916	627	677	577
	19.0	11.2	11.7	6.3	11.2
	3.3	—	1.1	0.0	2.9
	21.5	10.3	17.1	11.0	—
	1,179	938	657	694	592
	1,571	1,357	916	825	672
	3,826	3,482	2,906	2,582	2,231
Assets — additional as-filed lines
	9.9	9.9	—	3.4	—
Trade payables — MSME split
	0.6	1.2	11.5	—	—
	363	333	266	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

AARTIPHARM₹823.65

Aarti Pharmalabs Ltd.

· Pharma & Health

₹ CrorePeersAARTIDRUGS ADVENZYMES AGARWALEYE AKUMS ALIVUS APLLTD CORONA HCGMcap ₹7,467 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	922.7	1,014.7	1,104.1	1,335.9	1,465.9
+ Capital Work-in-Progress	62.2	78.5	306.6	305.2	308.2
+ Investment Property	—	0.0	—	65.5	65.5
+ Goodwill	1.8	1.8	1.8	0.0	0.0
+ Other Intangibles	1.3	16.9	30.7	36.0	34.6
+ Intangibles under Development	39.7	58.4	67.8	87.9	103.9
+ Investments (Equity Method)	—	36.8	—	—	—
+ Non-current Investments	35.5	0.0	29.2	193.8	203.8
+ Long-term Loans	0.0	5.9	7.3	7.8	8.0
+ Other Non-current Financial Assets	9.5	11.3	14.0	35.4	36.3
Non-current Financial Assets	45.0	17.2	50.6	237.1	248.1
+ Other Non-current Assets	2.5	12.3	22.7	16.8	8.6
Total Non-current Assets	1,075.2	1,236.5	1,584.2	2,084.4	2,169.3
Current Assets
+ Inventories	602.0	642.9	587.6	640.3	794.2
+ Current Investments	38.2	70.4	47.6	0.0	0.0
+ Trade Receivables	440.1	519.3	575.4	583.3	685.0
+ Cash & Cash Equivalents	24.9	23.6	6.7	8.5	4.2
+ Other Bank Balances	0.1	0.4	1.9	1.1	19.1
+ Short-term Loans	7.1	1.3	1.0	0.5	0.6
+ Other Current Financial Assets	35.8	6.3	5.1	153.6	0.2
Current Financial Assets	546.1	621.3	637.8	747.0	709.1
+ Other Current Assets	7.6	78.0	96.8	—	153.3
Total Current Assets	1,155.8	1,345.6	1,322.2	1,397.3	1,656.5
Total Assets	2,230.9	2,582.1	2,906.4	3,481.7	3,825.9
Equity
+ Equity Share Capital	45.3	45.3	45.3	45.3	45.3
+ Other Equity / Reserves	1,513.2	1,711.7	1,944.6	2,079.3	2,209.4
Equity — Owners of Parent	1,558.5	1,757.0	1,989.9	2,124.6	2,254.8
Total Equity	1,558.5	1,757.0	1,989.9	2,124.6	2,254.8
Liabilities
+ Borrowings — Non-current	0.2	0.0	103.6	185.8	159.8
+ Other Non-current Financial Liab	0.5	16.7	19.4	91.5	80.3
Non-current Financial Liabilities	0.7	16.7	122.9	277.3	240.2
+ Provisions — Non-current	1.3	6.1	8.1	7.9	9.1
+ Deferred Tax Liabilities	78.8	107.9	128.4	134.3	142.6
Non-current Liabilities	80.9	130.7	259.4	419.5	391.9
+ Borrowings — Current	213.8	264.1	292.8	499.8	676.6
+ Trade Payables	346.8	378.3	277.8	334.5	363.4
+ Other Current Financial Liab	16.9	34.7	56.4	81.7	95.4
Current Financial Liabilities	577.5	677.1	627.1	916.0	1,135.4
+ Provisions — Current	11.2	6.3	11.7	11.2	19.0
+ Current Tax Liabilities	2.9	0.0	1.1	—	3.3
+ Other Current Liabilities	—	11.0	17.1	10.3	21.5
Current Liabilities	591.6	694.4	657.0	937.6	1,179.2
Total Liabilities	672.5	825.1	916.5	1,357.1	1,571.1
Total Equity & Liabilities	2,230.9	2,582.1	2,906.4	3,481.7	3,825.9
Assets — additional as-filed lines
+ Current Tax Assets	—	3.4	—	9.9	9.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	11.5	1.2	0.6
+ Dues to Other Creditors — Current	—	—	266.3	333.4	362.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.